He reported receiving research grants from the National Institute for Health Research and the U.K. Medical Research Council, as well as more than a half-dozen pharmaceutical companies.
Dr. van Os reported having no financial conflicts.
News
Redefined schizoaffective disorder in DSM-5 seen as problematic
